Researchers have developed a vaccine, originally developed to protect against a strain of meningitis, has been shown to ward off gonorrhoea - a sexually transmitted infection. The findings mark the first time a vaccine has shown any protection against gonorrhoea and point to new avenues in the search for a specific vaccine to stop the global spread of 'super-gonorrhea'. They found that those who had been vaccinated were significantly less likely to have gonorrhoea.
According to they study, people who had received who had received the meningococcal B vaccine were 31 percent less likely to be infected with gonorrhoea than those who hadn’t received the meningococcal B vaccine. "This new research could be game-changing," said by an expert at the Meningitis Research Foundation who was not directly involved in the study. The findings "provide experimental evidence and a proof of principle"…
